Tharimmune

Tharimmune logo
🇺🇸United States
Ownership
Public
Employees
3
Market Cap
$3.3M
Website
http://tharimmune.com

TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis

Phase 2
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-12-13
Last Posted Date
2024-12-17
Lead Sponsor
Tharimmune Inc
Target Recruit Count
40
Registration Number
NCT06733519

An Evaluation of The Absolute Bioavailability of TH104

Phase 1
Active, not recruiting
Conditions
Interventions
First Posted Date
2024-01-10
Last Posted Date
2024-02-13
Lead Sponsor
Tharimmune Inc
Target Recruit Count
20
Registration Number
NCT06198686
Locations
🇺🇸

Novum Pharmaceutical Research Services, Las Vegas, Nevada, United States

© Copyright 2024. All Rights Reserved by MedPath